Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) EBT Margin (2020 - 2025)

iSpecimen has reported EBT Margin over the past 6 years, most recently at 5192.35% for Q4 2025.

  • Quarterly results put EBT Margin at 5192.35% for Q4 2025, down 478607.0% from a year ago — trailing twelve months through Dec 2025 was 465.33% (down 32694.0% YoY), and the annual figure for FY2025 was 465.33%, down 32694.0%.
  • EBT Margin for Q4 2025 was 5192.35% at iSpecimen, down from 2654.92% in the prior quarter.
  • Over the last five years, EBT Margin for ISPC hit a ceiling of 1.2% in Q4 2021 and a floor of 5192.35% in Q4 2025.
  • Median EBT Margin over the past 5 years was 102.24% (2023), compared with a mean of 498.97%.
  • Biggest five-year swings in EBT Margin: skyrocketed 13654bps in 2024 and later plummeted -478607bps in 2025.
  • iSpecimen's EBT Margin stood at 1.2% in 2021, then tumbled by -6187bps to 72.92% in 2022, then tumbled by -51bps to 109.83% in 2023, then crashed by -270bps to 406.28% in 2024, then tumbled by -1178bps to 5192.35% in 2025.
  • The last three reported values for EBT Margin were 5192.35% (Q4 2025), 2654.92% (Q3 2025), and 255.36% (Q2 2025) per Business Quant data.